1. The role of α-synuclein gene multiplications in early-onset Parkinson’s disease and dementia with Lewy bodies.
- Author
-
Hofer, A., Berg, D., Asmus, F., Niwar, M., Ransmayr, G., Riemenschneider, M., Bonelli, S.-B., Steffelbauer, M., Ceballos-Baumann, A., Haussermann, P., Behnke, S., Krüger, R., Prestel, J., Sharma, M., Zimprich, A., Riess, O., and Gasser, T.
- Subjects
PARKINSON'S disease ,LEWY body dementia ,GENES ,GENETIC mutation ,NEUROBEHAVIORAL disorders - Abstract
Background: A triplication of the α-synuclein gene was found to cause autosomal dominant Lewy body disease in two distinct families. Method: We searched for alterations of α-synuclein gene dosage and analysed the entire coding region for point mutations in 54 dementia with Lewy body disease (DLB) and in 103 young onset Parkinson’s disease (PD) patients from Central Europe. Results: We could not detect any quantitative alterations in the gene dosage of α-synuclein. Mutational screening of the entire coding region of α-synuclein revealed only one silent mutation V3V (adenine9guanine) in one case. Conclusions: Thus, this phenomenon appears not to be a major cause in the pathogenesis of sporadic DLB and young onset PD in this European population. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF